Condition: Respiratory Syncytial Virus Infections · Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory syncytial virus (RSV) is recognized worldwide as a significant pathogen causing lower respiratory tract infection in infants, the elderly, and immunocompromised patients, which may cause bronchiolitis or pneumonia, and affect the cardiovascular system, central nervous system and the renal system, resulting in hospitalization and death risks in children and also high-risk adults, particularly the elderly. The purpose of this study is to evaluate the efficacy of Ziresovir (AK0529) compared to placebo with respect to the time to resolution of RSV lower respiratory tract disease (LRTD) symptoms.
This description comes directly from the study's public registry record.
Chao Yu, Mater · +86 021-50681677 · chao.yu@arkbiosciences.com
Always discuss trial participation with your own doctor first.
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Guangzhou Medical University Panyu Central Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Cangzhou Hospital of Integrated TCM-WM | Cangzhou, Hebei, China | Recruiting |
| The First Affiliated Hospital of Nanyang Medical College | Nanyang, Henan, China | Recruiting |
| Henan Infectious Disease Hospital (The Sixth People's Hospital of Zhengzhou) | Zhengzhou, Henan, China | Not Yet Recruiting |
| Wuhan Sixth Hospital | Wuhan, Hubei, China | Recruiting |
| Zhejiang Hospital | Hangzhou, Zhejiang, China | Not Yet Recruiting |
| People's Hospital of Rui'an City | Rui’an, Zhejiang, China | Recruiting |
| Taizhou Hospital of Zhejiang Province | Taizhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07658534